STOCK TITAN

Planned sale of 171,750 AVAH shares disclosed in Form 144 filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An affiliated holder of AVAH common stock plans to sell 171,750 shares, with an aggregate market value of 1,361,978.00, through Morgan Stanley Smith Barney on the NASDAQ, with an approximate sale date of 02/19/2026.

The securities relate to restricted stock vesting on 02/14/2026, when 425,304 shares of common stock were acquired from the issuer. Over the prior three months, the same account sold 50,970 shares of common stock for gross proceeds of 413,942.66.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many AVAH shares are planned for sale under this Form 144?

171,750 shares of AVAH common stock are planned for sale. The filing lists an aggregate market value of 1,361,978.00, with Morgan Stanley Smith Barney handling the transaction on NASDAQ and an approximate sale date of 02/19/2026.

What recent AVAH stock sale activity is disclosed in this Form 144?

The notice reports a prior sale of 50,970 shares of AVAH common stock. That transaction occurred on 01/02/2026 and generated gross proceeds of 413,942.66, providing context for recent selling activity from the same account over the past three months.

How were the AVAH shares being sold under Rule 144 originally acquired?

The shares were acquired through restricted stock vesting on 02/14/2026. On that date, the filer obtained 425,304 shares of AVAH common stock from the issuer, with the form describing the payment terms as “Not Applicable,” indicating no separate cash purchase price at vesting.

Which broker and exchange are involved in the planned AVAH share sale?

The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services as broker. The planned sale of 171,750 AVAH common shares is to occur on the NASDAQ exchange, with Morgan Stanley’s New York office address provided in the disclosure.

What representation does the AVAH insider make about nonpublic information?

By signing the notice, the selling person represents they do not know any material adverse information about AVAH’s current or prospective operations that has not been publicly disclosed, as required in the standard Rule 144 Form 144 representation language included in the document.

What is the approximate timing of the AVAH stock sale under this notice?

The approximate date of sale for the 171,750 AVAH common shares is listed as 02/19/2026. This timing applies to the proposed NASDAQ transaction handled through Morgan Stanley Smith Barney, as disclosed in the securities information section of the notice.
Aveanna Healthcare Holdings, Inc.

NASDAQ:AVAH

AVAH Rankings

AVAH Latest News

AVAH Latest SEC Filings

AVAH Stock Data

1.66B
26.44M
Medical Care Facilities
Services-home Health Care Services
Link
United States
ATLANTA